257 related articles for article (PubMed ID: 30242671)
21. Helicobacter pylori-associated regulation of forkhead transcription factors FoxO1/3a in human gastric cells.
Tabassam FH; Graham DY; Yamaoka Y
Helicobacter; 2012 Jun; 17(3):193-202. PubMed ID: 22515357
[TBL] [Abstract][Full Text] [Related]
22. Metformin inhibits proliferation and migration of endometrial cancer cells through regulating PI3K/AKT/MDM2 pathway.
Qiang P; Shao Y; Sun YP; Zhang J; Chen LJ
Eur Rev Med Pharmacol Sci; 2019 Feb; 23(4):1778-1785. PubMed ID: 30840303
[TBL] [Abstract][Full Text] [Related]
23. Antineoplastic Activity of an Old Natural Antidiabetic Biguanide on the Human Thyroid Carcinoma Cell Line.
Nozhat Z; Zarkesh M; Baldini E; Mohammadi-Yeganeh S; Azizi F; Hedayati M
Anticancer Agents Med Chem; 2022; 22(4):713-720. PubMed ID: 33461474
[TBL] [Abstract][Full Text] [Related]
24. [Metformin induces apoptosis in hepatocellular carcinoma Huh-7 cells in vitro and its mechanism].
Lin F; Yan W; Wen T; Wu GY
Zhonghua Zhong Liu Za Zhi; 2013 Oct; 35(10):742-6. PubMed ID: 24378094
[TBL] [Abstract][Full Text] [Related]
25. M2‑like tumour‑associated macrophage‑secreted IGF promotes thyroid cancer stemness and metastasis by activating the PI3K/AKT/mTOR pathway.
Lv J; Liu C; Chen FK; Feng ZP; Jia L; Liu PJ; Yang ZX; Hou F; Deng ZY
Mol Med Rep; 2021 Aug; 24(2):. PubMed ID: 34184083
[TBL] [Abstract][Full Text] [Related]
26. miR-5188 augments glioma growth, migration and invasion through an SP1-modulated FOXO1-PI3K/AKT-c-JUN-positive feedback circuit.
Yi R; Yang S; Lin X; Zhong L; Liao Y; Hu Z; Huang T; Long H; Lin J; Wu Z; Xie C; Ding S; Luo J; Luo Q; Song Y
J Cell Mol Med; 2020 Oct; 24(20):11800-11813. PubMed ID: 32902145
[TBL] [Abstract][Full Text] [Related]
27. MicroRNA-146b promotes PI3K/AKT pathway hyperactivation and thyroid cancer progression by targeting PTEN.
Ramírez-Moya J; Wert-Lamas L; Santisteban P
Oncogene; 2018 Jun; 37(25):3369-3383. PubMed ID: 29353884
[TBL] [Abstract][Full Text] [Related]
28. The Akt-specific inhibitor MK2206 selectively inhibits thyroid cancer cells harboring mutations that can activate the PI3K/Akt pathway.
Liu R; Liu D; Trink E; Bojdani E; Ning G; Xing M
J Clin Endocrinol Metab; 2011 Apr; 96(4):E577-85. PubMed ID: 21289267
[TBL] [Abstract][Full Text] [Related]
29. Interleukin-11 promotes epithelial-mesenchymal transition in anaplastic thyroid carcinoma cells through PI3K/Akt/GSK3β signaling pathway activation.
Zhong Z; Hu Z; Jiang Y; Sun R; Chen X; Chu H; Zeng M; Sun C
Oncotarget; 2016 Sep; 7(37):59652-59663. PubMed ID: 27487122
[TBL] [Abstract][Full Text] [Related]
30. Metformin inhibits cervical cancer cell proliferation by modulating PI3K/Akt-induced major histocompatibility complex class I-related chain A gene expression.
Xia C; Liu C; He Z; Cai Y; Chen J
J Exp Clin Cancer Res; 2020 Jul; 39(1):127. PubMed ID: 32631421
[TBL] [Abstract][Full Text] [Related]
31. MicroRNA-96 plays an oncogenic role by targeting FOXO1 and regulating AKT/FOXO1/Bim pathway in papillary thyroid carcinoma cells.
Song HM; Luo Y; Li DF; Wei CK; Hua KY; Song JL; Xu H; Maskey N; Fang L
Int J Clin Exp Pathol; 2015; 8(9):9889-900. PubMed ID: 26617698
[TBL] [Abstract][Full Text] [Related]
32. FOXO1 functions in the regulation of nicotinamide phosphoribosyltransferase (Nampt) expression.
Jeong B; Park JW; Kim JG; Lee BJ
Biochem Biophys Res Commun; 2019 Apr; 511(2):398-403. PubMed ID: 30799084
[TBL] [Abstract][Full Text] [Related]
33. Down-Regulation of the Mammalian Target of Rapamycin (mTOR) Pathway Mediates the Effects of the Paeonol-Platinum(II) Complex in Human Thyroid Carcinoma Cells and Mouse SW1736 Tumor Xenografts.
He L; Guo S; Zhu T; Chen C; Xu K
Med Sci Monit; 2020 Jun; 26():e922561. PubMed ID: 32594094
[TBL] [Abstract][Full Text] [Related]
34. MiR-132 plays an oncogenic role in laryngeal squamous cell carcinoma by targeting FOXO1 and activating the PI3K/AKT pathway.
Lian R; Lu B; Jiao L; Li S; Wang H; Miao W; Yu W
Eur J Pharmacol; 2016 Dec; 792():1-6. PubMed ID: 27751825
[TBL] [Abstract][Full Text] [Related]
35. AKT-phosphorylated FOXO1 suppresses ERK activation and chemoresistance by disrupting IQGAP1-MAPK interaction.
Pan CW; Jin X; Zhao Y; Pan Y; Yang J; Karnes RJ; Zhang J; Wang L; Huang H
EMBO J; 2017 Apr; 36(8):995-1010. PubMed ID: 28279977
[TBL] [Abstract][Full Text] [Related]
36. Protective action of liraglutide in beta cells under lipotoxic stress via PI3K/Akt/FoxO1 pathway.
Shao S; Nie M; Chen C; Chen X; Zhang M; Yuan G; Yu X; Yang Y
J Cell Biochem; 2014 Jun; 115(6):1166-75. PubMed ID: 24415347
[TBL] [Abstract][Full Text] [Related]
37. Down-regulation of miRNA-196b expression inhibits the proliferation, migration and invasiveness of HepG2 cells while promoting their apoptosis via the PI3K/Akt signaling pathway.
Xu F; Zhu F; Wang W; Gao W; Chen X; Yu C
Cell Mol Biol (Noisy-le-grand); 2020 Jun; 66(3):159-164. PubMed ID: 32538764
[TBL] [Abstract][Full Text] [Related]
38. Involvement of FoxO1 in the effects of follicle-stimulating hormone on inhibition of apoptosis in mouse granulosa cells.
Shen M; Liu Z; Li B; Teng Y; Zhang J; Tang Y; Sun SC; Liu H
Cell Death Dis; 2014 Oct; 5(10):e1475. PubMed ID: 25321482
[TBL] [Abstract][Full Text] [Related]
39. FOXO1 controls thyroid cell proliferation in response to TSH and IGF-I and is involved in thyroid tumorigenesis.
Zaballos MA; Santisteban P
Mol Endocrinol; 2013 Jan; 27(1):50-62. PubMed ID: 23160481
[TBL] [Abstract][Full Text] [Related]
40. LDHA deficiency inhibits trophoblast proliferation via the PI3K/AKT/FOXO1/CyclinD1 signaling pathway in unexplained recurrent spontaneous abortion.
Zhu Y; Wu F; Hu J; Xu Y; Zhang J; Li Y; Lin Y; Liu X
FASEB J; 2023 Feb; 37(2):e22744. PubMed ID: 36583693
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
